All-trans retinoic acid (ATRA) and tranexamic acid: A potentially fatal combination in acute promyelocytic leukaemia [7]

British Journal of Haematology

Volumn 110, Issue 4, 2000, Pages 1010-1012

  Brown, J E ^a   Olujohungbe, A ^a   Chang, J ^a   Ryder, W D J ^a   Morganstern, G R ^a   Chopra, R ^a   Scarffe, J H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Acute promyelocytic leukaemia; ATRA; Tranexamic acid

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIFIBRINOLYTIC AGENT; CYTARABINE; DAUNORUBICIN; RETINOIC ACID; TIOGUANINE; TRANEXAMIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; BLEEDING; BLOOD CLOT LYSIS; CAUSE OF DEATH; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; LETTER; MALE; MORTALITY; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ADULT; ANTIFIBRINOLYTIC AGENTS; ANTINEOPLASTIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; THROMBOSIS; TRANEXAMIC ACID; TRETINOIN;

EID: 0033755112     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02270-8.x     Document Type: Letter

References (6)

1. All-trans retinoic acid in promyelocytic leukemias II, in vitro studies: Structure function relationship
2. Coagulation disorders associated with acute promyelocytic leukaemia: Corrective effect of all-trans retinoic acid treatment
3. Treatment of acute promyelocytic leukaemia
4. All-trans retinoic acid (ATRA) as first line therapy of APL: A report of 31 cases
5. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage
6. All-trans retinoic acid in acute promyelocytic leukemia